Abstract | BACKGROUND: Although several studies have confirmed the association of xenotropic murine leukemia virus-related virus (XMRV) and prostate cancer, this association is still controversial, as most studies did not detect XMRV in prostate tissue samples. Furthermore, some genetic and epidemiological studies have highlighted a role for RNase L polymorphisms, particularly R462Q, in the progression of prostate cancer. OBJECTIVES: The focus of this study was on the association of XMRV and RNase L R462Q variants with the risk of prostate cancer in Iranian patients. PATIENTS AND METHODS: In this case-control study, 40 and 80 individuals with sporadic prostate cancer and benign prostatic hyperplasia, respectively, were included. The presence of XMRV was evaluated by real-time polymerase chain reaction (PCR) of integrase and nested-PCR for the gag genes. The RNase L R462Q polymorphism analysis was carried out by PCR and sequencing. RESULTS: CONCLUSIONS: These results did not support the presence of XMRV in the samples with prostate cancer and showed that RNase L R462Q variants had relatively little or no impact on the risk of prostate cancer in Iranian population.
|
Authors | Farhad Babaei, Ali Ahmadi, Farhad Rezaei, Somayeh Jalilvand, Nastaran Ghavami, Mahmoud Mahmoudi, Ramin Abiri, Nasim Kondori, Rakhshande Nategh, Talat Mokhtari Azad |
Journal | Iranian Red Crescent medical journal
(Iran Red Crescent Med J)
Vol. 17
Issue 12
Pg. e19439
(Dec 2015)
ISSN: 2074-1804 [Print] Estonia |
PMID | 26744630
(Publication Type: Journal Article)
|